{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:50:19Z","timestamp":1768351819408,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Our goal was to describe the characteristics and posttreatment outcomes of pediatric patients with central nervous system (CNS) tuberculosis (TB) and to identify factors associated with poor outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included children aged 0 to 18 years with CNS TB reported to the California TB registry between 1993 and 2011. Demographics, clinical characteristics, severity of disease at presentation (Modified Medical Research Council stage I, II, or III [III is most severe]), treatment, and outcomes during the year after treatment completion were abstracted systematically from the medical and public health records. Patient outcomes were categorized as good or poor on the basis of disability in hearing, vision, language, ambulation, and development and other neurologic deficits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 151 pediatric CNS TB cases reported between 1993 and 2011 in California for which records were available, 92 (61%) cases included sufficient information to determine outcome. Overall, 55 (60%) children had a poor outcome. After we adjusted for age (0 to 4 years), children with stage III severity (vs I or II; prevalence rate ratio [PRR], 1.4 [95% confidence interval (CI), 1.1\u20131.9]), a protein concentration of &gt;100 mg\/dL on initial lumbar puncture (PRR, 1.2 [95% CI, 1.03\u20131.4]), or infarct on neuroimaging (PRR, 1.2 [95% CI, 1.04\u20131.3]) were at increased risk for a poor outcome. In multivariate analysis, an age of 0 to 4 years (vs &gt;4 years; PRR, 1.4 [95% CI, 1.2\u20131.7]) and a stage II or III Modified Medical Research Council score (vs stage I; PRR, 1.2 [95% CI, 1.03\u20131.5]) remained significantly associated with poor outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Pediatric patients with CNS TB in California are left with high rates of disabling clinical sequelae after treatment. The identification of modifiable factors is critical for improving outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpids\/piy084","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T07:19:46Z","timestamp":1533799186000},"page":"439-449","source":"Crossref","is-referenced-by-count":9,"title":["Outcomes of Pediatric Central Nervous System Tuberculosis in California, 1993\u20132011"],"prefix":"10.1093","volume":"8","author":[{"given":"Alexandra","family":"Duque-Silva","sequence":"first","affiliation":[{"name":"UCSF Benioff Children\u2019s Hospital of Oakland, California"},{"name":"Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Hampole","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ning","family":"Cheng","sequence":"additional","affiliation":[{"name":"Tuberculosis Control and Refugee Health Branch, San Diego Health and Human Services Agency, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Flood","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-1890","authenticated-orcid":false,"given":"Pennan M","family":"Barry","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"2019110600561050600_CIT0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00042-07","article-title":"Central nervous system tuberculosis: pathogenesis and clinical aspects","volume":"21","author":"Rock","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2019110600561050600_CIT0002","doi-asserted-by":"crossref","first-page":"e1276","DOI":"10.1542\/peds.2014-3958","article-title":"Risk factors for central nervous system tuberculosis","volume":"136","author":"Duque-Silva","year":"2015","journal-title":"Pediatrics"},{"key":"2019110600561050600_CIT0003","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1473-3099(14)70852-7","article-title":"Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis","volume":"14","author":"Chiang","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2019110600561050600_CIT0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1468-1331.2006.01534.x","article-title":"Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis","volume":"14","author":"Kalita","year":"2007","journal-title":"Eur J Neurol"},{"key":"2019110600561050600_CIT0005","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1542\/peds.102.5.e49","article-title":"Central nervous system tuberculosis in children: a review of 214 cases","volume":"102","author":"Yarami\u015f","year":"1998","journal-title":"Pediatrics"},{"key":"2019110600561050600_CIT0006","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1469-8749.2002.tb00323.x","article-title":"Long-term follow up of childhood tuberculous meningitis","volume":"44","author":"Schoeman","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"2019110600561050600_CIT0007","first-page":"261","article-title":"Outcome of tuberculous meningitis at 6 and 12 months: a multiple regression analysis","volume":"3","author":"Kalita","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019110600561050600_CIT0008","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-1353","article-title":"Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa","volume":"123","author":"van Well","year":"2009","journal-title":"Pediatrics"},{"key":"2019110600561050600_CIT0009","first-page":"64","article-title":"Predictors of outcome in patients with tuberculous meningitis","volume":"6","author":"Hosoglu","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019110600561050600_CIT0010","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1177\/0883073816668112","article-title":"Predictors of neurological outcome of tuberculous meningitis in childhood: a prospective cohort study from a developing country","volume":"31","author":"Dhawan","year":"2016","journal-title":"J Child Neurol"},{"key":"2019110600561050600_CIT0011","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5588\/ijtld.11.0648","article-title":"Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitis","volume":"16","author":"van Toorn","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"2019110600561050600_CIT0012","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1474-4422(05)70019-3","article-title":"Tuberculous meningitis: many questions, too few answers","volume":"4","author":"Thwaites","year":"2005","journal-title":"Lancet Neurol"},{"key":"2019110600561050600_CIT0013","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","article-title":"Tuberculous meningitis: a uniform case definition for use in clinical research","volume":"10","author":"Marais","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2019110600561050600_CIT0014","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences","volume":"162","author":"Spiegelman","year":"2005","journal-title":"Am J Epidemiol"},{"key":"2019110600561050600_CIT0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3476(95)70252-0","article-title":"Clinical and public health aspects of tuberculous meningitis in children","volume":"127","author":"Doerr","year":"1995","journal-title":"J Pediatr"},{"key":"2019110600561050600_CIT0016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.inf.0000154321.61866.2d","article-title":"Prediction of neurologic sequelae in childhood tuberculous meningitis: a review of 20 cases and proposal of a novel scoring system","volume":"24","author":"Saitoh","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"2019110600561050600_CIT0017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/INF.0000000000000065","article-title":"Short intensified treatment in children with drug-susceptible tuberculous meningitis","volume":"33","author":"van Toorn","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"2019110600561050600_CIT0018","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MAJ.0b013e3181a590f1","article-title":"Predictors for outcome and treatment delay in patients with tuberculous meningitis","volume":"338","author":"Sheu","year":"2009","journal-title":"Am J Med Sci"},{"key":"2019110600561050600_CIT0019","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s40471-016-0076-6","article-title":"Getting to zero: tuberculosis elimination in California","volume":"3","author":"Barry","year":"2016","journal-title":"Curr Epidemiol Rep"},{"key":"2019110600561050600_CIT0020","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1473-3099(17)30248-7","article-title":"Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA","volume":"17","author":"LoBue","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019110600561050600_CIT0021","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"US Preventive Services Task Force","year":"2016","journal-title":"JAMA"},{"key":"2019110600561050600_CIT0022","volume-title":"Guidance for National Tuberculosis Programmes on the Managment of Tuberculosis in Children","author":"World Health Organization","year":"2014","edition":"2nd ed"},{"key":"2019110600561050600_CIT0023","volume-title":"Guidelines for the Treatment of Active Tuberculosis Disease","author":"California Tuberculosis Controllers Association","year":"2003"},{"key":"2019110600561050600_CIT0024","volume-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC","author":"National Tuberculosis Controllers Association, Centers for Disease Control and Prevention","year":"2005"},{"key":"2019110600561050600_CIT0025","first-page":"805","article-title":"Tuberculosis","volume-title":"Red Book: 2015 report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2015"},{"key":"2019110600561050600_CIT0026","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019110600561050600_CIT0027","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2019110600561050600_CIT0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2019110600561050600_CIT0029","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1507062","article-title":"Therapy for tuberculous meningitis","volume":"374","author":"Heemskerk","year":"2016","journal-title":"N Engl J Med"},{"key":"2019110600561050600_CIT0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/INF.0000000000001114","article-title":"Linezolid is associated with improved early outcomes of childhood tuberculous meningitis","volume":"35","author":"Li","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2019110600561050600_CIT0031","first-page":"CD002244","article-title":"Corticosteroids for managing tuberculous meningitis","volume":"4","author":"Prasad","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2019110600561050600_CIT0032","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","article-title":"Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections","volume":"148","author":"Tobin","year":"2012","journal-title":"Cell"},{"key":"2019110600561050600_CIT0033","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/INF.0000000000000539","article-title":"Clinicoradiologic response of neurologic tuberculous mass lesions in children treated with thalidomide","volume":"34","author":"van Toorn","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2019110600561050600_CIT0034","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1212\/WNL.51.6.1710","article-title":"Lumbar and ventricular CSF protein, leukocytes, and lactate in suspected bacterial CNS infections","volume":"51","author":"Gerber","year":"1998","journal-title":"Neurology"},{"key":"2019110600561050600_CIT0035","doi-asserted-by":"crossref","first-page":"R491","DOI":"10.1186\/cc2972","article-title":"Case report: greater meningeal inflammation in lumbar than in ventricular region in human bacterial meningitis","volume":"8","author":"Naija","year":"2004","journal-title":"Crit Care"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/8\/5\/439\/30437008\/piy084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/8\/5\/439\/30437008\/piy084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:56:52Z","timestamp":1573001812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/8\/5\/439\/5090672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,9,4]]},"published-print":{"date-parts":[[2019,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piy084","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2018,9,4]]}}}